Psoriasis Patients Are Enriched for Genetic Variants That Protect against HIV-1 Disease

English version České info

An important paradigm in evolutionary genetics is that of a delicate balance between genetic variants that favorably boost host control of infection but which may unfavorably increase susceptibility to autoimmune disease. Here, we investigated whether patients with psoriasis, a common immune-mediated disease of the skin, are enriched for genetic variants that limit the ability of HIV-1 virus to replicate after infection. We analyzed the HLA class I and class II alleles of 1,727 Caucasian psoriasis cases and 3,581 controls and found that psoriasis patients are significantly more likely than controls to have gene variants that are protective against HIV-1 disease. This includes several HLA class I alleles associated with HIV-1 control; amino acid residues at HLA-B positions 67, 70, and 97 that mediate HIV-1 peptide binding; and the deletion polymorphism rs67384697 associated with high surface expression of HLA-C. We also found that the compound genotype KIR3DS1 plus HLA-B Bw4-80I, which respectively encode a natural killer cell activating receptor and its putative ligand, significantly increased psoriasis susceptibility. This compound genotype has also been associated with delay of progression to AIDS. Together, our results suggest that genetic variants that contribute to anti-viral immunity may predispose to the development of psoriasis.

Vyšlo v časopise: Psoriasis Patients Are Enriched for Genetic Variants That Protect against HIV-1 Disease. PLoS Genet 8(2): e32767. doi:10.1371/journal.pgen.1002514
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002514

Souhrn

Zdroje

1. KimNThrashBMenterA 2010 Comorbidities in psoriasis patients. Semin Cutan Med Surg 29 10 15

2. FarberEMNallMLWatsonW 1974 Natural history of psoriasis in 61 twin pairs. Arch Dermatol 109 207 211

3. BhaleraoJBowcockAM 1998 The genetics of psoriasis: a complex disorder of the skin and immune system. Hum Mol Genet 7 1537 1545

4. NairRPStuartPENistorIHiremagaloreRChiaNV 2006 Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 78 827 851

5. TomfohrdeJSilvermanABarnesRFernandez-VinaMAYoungM 1994 Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264 1141 1145

6. VealCDCaponFAllenMHHeathEKEvansJC 2002 Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus. Am J Hum Genet 71 554 564

7. HuffmeierUUebeSEkiciABBowesJGiardinaE 2010 Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 42 996 999

8. LiuYHelmsCLiaoWZabaLCDuanS 2008 A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 4 e1000041 doi:10.1371/journal.pgen.1000041

9. NairRPDuffinKCHelmsCDingJStuartPE 2009 Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41 199 204

10. StrangeACaponFSpencerCCKnightJWealeME 2010 A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42 985 990

11. StuartPENairRPEllinghausEDingJTejasviT 2010 Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet 42 1000 1004

12. DeeksSGWalkerBD 2007 Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27 406 416

13. FellayJGeDShiannaKVColomboSLedergerberB 2009 Common genetic variation and the control of HIV-1 in humans. PLoS Genet 5 e1000791 doi:10.1371/journal.pgen.1000791

14. FellayJShiannaKVGeDColomboSLedergerberB 2007 A whole-genome association study of major determinants for host control of HIV-1. Science 317 944 947

15. PereyraFJiaXMcLarenPJTelentiAde BakkerPI 2010 The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330 1551 1557

16. ThomasRAppsRQiYGaoXMaleV 2009 HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet 41 1290 1294

17. MorarNWillis-OwenSAMaurerTBunkerCB 2010 HIV-associated psoriasis: pathogenesis, clinical features, and management. Lancet Infect Dis 10 470 478

18. ObuchMLMaurerTABeckerBBergerTG 1992 Psoriasis and human immunodeficiency virus infection. J Am Acad Dermatol 27 667 673

19. SadickNSMcNuttNSKaplanMH 1990 Papulosquamous dermatoses of AIDS. J Am Acad Dermatol 22 1270 1277

20. FifeDJWallerJMJeffesEWKooJY 2007 Unraveling the paradoxes of HIV-associated psoriasis: a review of T-cell subsets and cytokine profiles. Dermatol Online J 13 4

21. RoedererMDubsJGAndersonMTRajuPAHerzenbergLA 1995 CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 95 2061 2066

22. TorresBAJohnsonHM 1994 Identification of an HIV-1 Nef peptide that binds to HLA class II antigens. Biochem Biophys Res Commun 200 1059 1065

23. DiltheyATMoutsianasLLeslieSMcVeanG 2011 HLA*IMP–an integrated framework for imputing classical HLA alleles from SNP genotypes. Bioinformatics 27 968 972

24. AltfeldMAddoMMRosenbergESHechtFMLeePK 2003 Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 17 2581 2591

25. CatanoGKulkarniHHeWMarconiVCAganBK 2008 HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS ONE 3 e3636 doi:10.1371/journal.pone.0003636

26. KaslowRACarringtonMAppleRParkLMunozA 1996 Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 2 405 411

27. MiguelesSASabbaghianMSShupertWLBettinottiMPMarincolaFM 2000 HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A 97 2709 2714

28. CarringtonMNelsonGWMartinMPKissnerTVlahovD 1999 HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283 1748 1752

29. CarringtonMO'BrienSJ 2003 The influence of HLA genotype on AIDS. Annu Rev Med 54 535 551

30. GaoXNelsonGWKarackiPMartinMPPhairJ 2001 Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 344 1668 1675

31. HLA Nomenclature. Accessed 2012 Jan 06. http://hla.alleles.org/alleles/index.html

32. RechePAReinherzEL 2003 Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. J Mol Biol 331 623 641

33. Wellcome Trust Case Control C 2007 Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 661 678

34. ChoJHBrantSR 2011 Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 140 1704 1712

35. ElliottTWilliamsA 2005 The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex. Immunol Rev 207 89 99

36. WilliamsAPPehCAPurcellAWMcCluskeyJElliottT 2002 Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 16 509 520

37. KulkarniSSavanRQiYGaoXYukiY 2011 Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472 495 498

38. BarbourJDSriramUCaillierSJLevyJAHechtFM 2007 Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog 3 e43 doi:10.1371/journal.ppat.0030043

39. BouletSSharafiSSimicNBruneauJRoutyJP 2008 Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS 22 595 599

40. JennesWVerheydenSDemanetCAdje-ToureCAVuylstekeB 2006 Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol 177 6588 6592

41. LongBRNdhlovuLCOksenbergJRLanierLLHechtFM 2008 Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. J Virol 82 4785 4792

42. MartinMPGaoXLeeJHNelsonGWDetelsR 2002 Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31 429 434

43. RavetSScott-AlgaraDBonnetETranHKTranT 2007 Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 109 4296 4305

44. CellaMLongoAFerraraGBStromingerJLColonnaM 1994 NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 180 1235 1242

45. KiepielaPLeslieAJHoneyborneIRamduthDThobakgaleC 2004 Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432 769 775

46. FengBJSunLDSoltani-ArabshahiRBowcockAMNairRP 2009 Multiple Loci within the major histocompatibility complex confer risk of psoriasis. PLoS Genet 5 e1000606 doi:10.1371/journal.pgen.1000606

47. CaoKHollenbachJShiXShiWChopekM 2001 Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 62 1009 1030

48. GladmanDDAnhornKASchachterRKMervartH 1986 HLA antigens in psoriatic arthritis. J Rheumatol 13 586 592

49. MarsalSArmadans-GilLMartinezMGallardoDRiberaA 1999 Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford) 38 332 337

50. RahmanPRoslinNMPellettFJLemireMGreenwoodCM 2011 High resolution mapping in the major histocompatibility complex region identifies multiple independent novel loci for psoriatic arthritis. Ann Rheum Dis 70 690 694

51. Torre AlonsoJCRodriguez PerezAArribas CastrilloJMBallina GarciaJRiestra NoriegaJL 1991 Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 30 245 250

52. HolmSJSakurabaKMallbrisLWolkKStahleM 2005 Distinct HLA-C/KIR genotype profile associates with guttate psoriasis. J Invest Dermatol 125 721 730

53. LuszczekWManczakMCisloMNockowskiPWisniewskiA 2004 Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum Immunol 65 758 766

54. MartinMPNelsonGLeeJHPellettFGaoX 2002 Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 169 2818 2822

55. WilliamsFMeenaghASleatorCCookDFernandez-VinaM 2005 Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis. Hum Immunol 66 836 841

56. NogralesKEBrasingtonRDBowcockAM 2009 New insights into the pathogenesis and genetics of psoriatic arthritis. Nat Clin Pract Rheumatol 5 83 91

57. BarreiroLBQuintana-MurciL 2010 From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat Rev Genet 11 17 30

58. LiYLiaoWCargillMChangMMatsunamiN 2010 Carriers of rare missense variants in IFIH1 are protected from psoriasis. J Invest Dermatol 130 2768 2772

59. NestleFOKaplanDHBarkerJ 2009 Psoriasis. N Engl J Med 361 496 509

60. CicconeEJGreenwaldJHLeePIBiancottoAReadSW 2011 CD4+ T Cells, Including Th17 and Cycling Subsets, Are Intact in the Gut Mucosa of HIV-1-Infected Long-Term Nonprogressors. J Virol 85 5880 5888

61. OwenREHeitmanJWHirschkornDFLanteriMCBiswasHH 2010 HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses. AIDS 24 1095 1105

62. SalgadoMRallonNIRodesBLopezMSorianoV 2011 Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors. Clin Immunol 139 110 114

63. MallonEYoungDBunceMGotchFMEasterbrookPJ 1998 HLA-Cw*0602 and HIV-associated psoriasis. Br J Dermatol 139 527 533

64. ReveilleJDConantMADuvicM 1990 Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: a disease continuum? Arthritis Rheum 33 1574 1578

65. ZhernakovaAElbersCCFerwerdaBRomanosJTrynkaG 2010 Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet 86 970 977

66. ArcaroliJFesslerMBAbrahamE 2005 Genetic polymorphisms and sepsis. Shock 24 300 312

67. NamathAPattersonAJ 2009 Genetic polymorphisms in sepsis. Crit Care Clin 25 835 856, x

68. HelmsCSacconeNLCaoLDawJACaoK 2005 Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR. Hum Genet 118 466 476

69. PurcellSNealeBTodd-BrownKThomasLFerreiraMA 2007 PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 559 575

70. PriceALPattersonNJPlengeRMWeinblattMEShadickNA 2006 Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38 904 909

71. BarcellosLFMaySLRamsayPPQuachHLLaneJA 2009 High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet 5 e1000696 doi:10.1371/journal.pgen.1000696

72. KulkarniSMartinMPCarringtonM 2009 KIR genotyping by multiplex PCR-SSP. Methods Mol Biol 612 365 375

73. HsuKCLiuXRSelvakumarAMickelsonEO'ReillyRJ 2002 Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 169 5118 5129